Stimulation of pancreatic islets with glucose induces phospholipid hydrolysis and accumulation of nonesterified arachidonic acid, which may amplify the glucose-induced Ca 2ϩ entry into islet ␤-cells that triggers insulin secretion. Ca 2ϩ loss from ␤-cell intracellular compartments has been proposed to induce both Ca 2ϩ entry and events dependent on arachidonate metabolism. We examine here effects of inducing Ca 2ϩ loss from intracellular sequestration sites with ionophore A23187 and thapsigargin on arachidonate hydrolysis from islet phospholipids. A23187 induces a decline in islet arachidonate-containing phospholipids and release of nonesterified arachidonate. A23187-induced arachidonate release is of similar magnitude when islets are stimulated in Ca 2ϩ -replete or in Ca 2ϩ -free media or when islets loaded with the intracellular Ca 2ϩ chelator BAPTA are stimulated in Ca 2ϩ -free medium, a condition in which A23187 induces no rise in ␤-cell cytosolic [Ca 2ϩ ]. Thapsigargin also induces islet arachidonate release under these conditions. A23187-or thapsigargininduced arachidonate release is prevented by a bromoenol lactone (BEL) inhibitor of a ␤-cell phospholipase A 2 (iPLA 2 ), which does not require Ca 2ϩ for catalytic activity and which is negatively modulated by and physically interacts with calmodulin by Ca 2ϩ -dependent mechanisms. Agents that cause Ca 2ϩ loss from islet intracellular compartments thus induce arachidonate hydrolysis from phospholipids by a BEL-sensitive mechanism that does not require a rise in cytosolic [Ca 2ϩ ], and a BEL-sensitive enzyme-like iPLA 2 or a related membranous activity may participate in sensing Ca 2ϩ compartment content. (Endocrinology 139: [4073][4074][4075][4076][4077][4078][4079][4080][4081][4082][4083][4084][4085] 1998) 
ulated in Ca 2ϩ -free medium, a condition in which A23187 induces no rise in ␤-cell cytosolic [Ca 2ϩ ]. Thapsigargin also induces islet arachidonate release under these conditions. A23187-or thapsigargininduced arachidonate release is prevented by a bromoenol lactone (BEL) inhibitor of a ␤-cell phospholipase A 2 (iPLA 2 ), which does not require Ca 2ϩ for catalytic activity and which is negatively modulated by and physically interacts with calmodulin by Ca 2ϩ -dependent mechanisms. Agents that cause Ca 2ϩ loss from islet intracellular compartments thus induce arachidonate hydrolysis from phospholipids by a BEL-sensitive mechanism that does not require a rise in cytosolic [Ca 2ϩ ], and a BEL-sensitive enzyme-like iPLA 2 or a related membranous activity may participate in sensing Ca 2ϩ compartment content. (Endocrinology 139: [4073] [4074] [4075] [4076] [4077] [4078] [4079] [4080] [4081] [4082] [4083] [4084] [4085] 1998) N ORMAL pancreatic islet ␤-cells maintain euglycemia by secreting insulin when the blood glucose concentration rises above 5 mm. Because this response is defective in type II diabetes mellitus (1), mechanisms underlying glucose-induced insulin secretion are biomedically important. Early events in this process include glucose transport into ␤-cells, its phosphorylation by glucokinase, and subsequent metabolism (2) , which yields signals that inactivate plasma membrane ATP-sensitive K ϩ channels (K ATP ) 1 (3, 4) . This causes membrane depolarization, opening of voltage-operated Ca 2ϩ channels, Ca 2ϩ influx, and a rise in cytosolic [Ca 2ϩ ] that triggers insulin exocytosis (5) (6) (7) . Glucose also induces hydrolysis of arachidonic acid from islet membrane phospholipids, and the resultant accumulation of nonesterified arachidonate (8, 9) may amplify depolarization-induced Ca 2ϩ influx (10) and insulin secretion (9) . How glucose induces hydrolysis of arachidonate from islet phospholipids is incompletely understood, but some findings raise the question of whether a decline in Ca 2ϩ content of subcellular compartments could participate in initiating this process. Glucose-stimulated ␤-cells first exhibit a transient decline in cytosolic [Ca 2ϩ ] (11) (12) (13) . It has been proposed that this is followed by Ca 2ϩ release from intracellular sequestration sites (14 -16) that results in activation of an inward cationic current across the plasma membrane (17, 18) that interacts cooperatively with K ATP channel closure to induce membrane depolarization and voltage-operated Ca 2ϩ channel opening (19) . It is not known what signal(s) generated by Ca 2ϩ loss from intracellular sites might influence plasma membrane ion fluxes. Because arachidonate affects activities of several ion channels (20 -24) and promotes Ca 2ϩ influx into ␤-cells (10, 25) , it is one candidate for a diffusible mediator that might convey signals from internal membranes to the plasma membrane, if it were released as a consequence of Ca 2ϩ loss from intracellular sites. That such release might occur is suggested by a report that agents that cause Ca 2ϩ loss from intracellular sites induce apoptosis in ␤-cells by a mechanism that requires generation of arachidonate lipoxygenase products and is blocked by lipoxygenase inhibitors and mimicked by the lipoxygenase product 12-HETE (26) . Although not directly demonstrated, this implies that agents that induce Ca 2ϩ loss from intracellular sites trigger hydrolysis of arachidonate from ␤-cell phospholipids because that is the rate-limiting event in producing arachidonate metabolites (27) , and nonesterified arachidonate levels govern islet 12-HETE production (28) . Induction of apoptosis in this system does not require a rise in cytosolic [Ca 2ϩ ] and occurs in Ca 2ϩ -free medium and in ␤-cells loaded with the Ca 2ϩ chelator BAPTA (26) . This implies that hydrolysis of arachidonate from ␤-cell phospholipids might also be triggered by a mechanism that does not require a rise in cytosolic [Ca 2ϩ ] but is activated by Ca 2ϩ loss from intracellular sites. The study reported here tests this hypothesis under conditions of short-term exposure of islets to agents that induce Ca 2ϩ -loss from intracellular sequestration sites, which may be more germane to acute signal transduction events than the longer term exposure required to induce apoptosis.
Islets were isolated from male Sprague-Dawley rats as described (29) by collagenase digestion of excised, minced pancreas, density gradient isolation, and manual selection under microscopic visualization. To examine responses to A23187 in Ca 2ϩ -replete medium, islets (300 per condition) were placed in silanized glass tubes containing 0.4 ml KRB (with 6 mm glucose and 0.1% BSA) and ethanol only (0.1%) or A23187 (10 m) in ethanol. Incubations (30 min, 37 C) were performed under 5% CO 2 /95% air and terminated by adding chloroform/methanol (2 ml, 1/1, vol/vol). Islet lipids were extracted and analyzed as described below. Similar experiments were performed with thapsigargin (5 m) in dimethylsulfoxide vehicle. To examine responses to agonists in Ca 2ϩ -free medium, preincubations (15 min) and experimental incubations (30 min) were performed in zero-calcium buffer (25 mm HEPES, pH 7.4, 115 mm NaCl, 24 mm NaHCO 3 , 5 mm KCl, 1 mm MgCl 2 , 6 mm glucose, 0.1% BSA) containing 1 mm EGTA and no added Ca 2ϩ . To examine effects of BAPTA, BEL, or propranolol, islets were preincubated (15 min) with BAPTA-AM (100 m), BEL (10 m), or propranolol (250 m) in cCMRL medium. Medium was then removed and islets rinsed thrice in zerocalcium buffer before experimental incubations (30 min). When propranolol was used, experimental incubation media also contained the agent (250 m). Under all loading and incubation conditions, cell viability exceeded 98% by trypan blue exclusion. Islet insulin content was determined as described (30) by RIA after extraction with 75% ethanol/ 1.5% HCl.
Extraction of islet lipids and addition of internal standards
To examine islet phospholipids, the chloroform/methanol (2 ml, 1/1, vol/vol) solution used to terminate incubations contained the internal standards (15:0/15:0)-GPE (3 nmol) and (14:0/14:0)-GPC (3.7 nmol). After removing incubation medium and adding this solution, islets were sonicated (30 sec, on ice, 30% power, Branson Sonifier, Danbury, CT). Chloroform/methanol (2 mL, 1/1, vol/vol) and water (1.8 mL) were then added and samples vortex-mixed and centrifuged (900 ϫ g, 5 min). The chloroform phase was placed in a silanized glass tube, concentrated to dryness, reconstituted, and analyzed by electrospray ionization (ESI) mass spectrometry (MS). To examine release of nonesterified arachidonate, the chloroform/methanol (2 ml, 1/1, vol/vol) solution used to terminate incubations contained acetic acid (0.3%) and [ 2 H 8 ]-arachidonic acid (3 nmol) internal standard. After adding this solution, samples were vortex-mixed and centrifuged (900 ϫ g, 5 min). The chloroform phase was placed in a silanized glass tube, concentrated to dryness, reconstituted, and analyzed by RP-HPLC and GC/MS.
Electrospray ionization mass spectrometric analysis of islet phospholipids
ESI/MS was performed on a Finnigan (San Jose, CA) TSQ-7000 triple stage quadrupole mass spectrometer equipped with an ESI source controlled by Finnigan ICIS software operated on a DEC alpha workstation. Phospholipids were dissolved in methanol/chloroform (9/1, vol/vol) containing LiOH (2 nmol/l) to facilitate formation of glycerophosphoethanolamine (GPE) (M-H) Ϫ ions for negative ion analyses and of Li ϩ adducts of glycerophoshocholine (GPC) for positive ion analyses. Samples were infused (1 l/min) into the ESI/MS system with a Harvard syringe pump and analyzed under described instrumental conditions (31, 32) . For tandem MS, precursor ions selected in the first quadrupole were accelerated (32-36 eV collision energy) into a chamber containing argon (2.3-2.5 mtorr) to induce collisionally activated dissociation (CAD) and product ions analyzed in the final quadrupole. To identify arachidonate-containing GPE species, negative ion tandem MS scanning was performed to identify parent ions that yielded arachidonate anion (m/z 303) as a product upon CAD. To identify arachidonate-containing GPC species, positive ion tandem MS scanning was performed to identify parent ions that yielded a product ion at m/z 473, which represents the arachidonoyl-glycerophosphoethanol moiety derived from GPC-Li ϩ adducts (31) .
Reverse phase HPLC isolation and derivatization of nonesterified arachidonic acid
Islet lipid extracts containing [ 2 H 8 ]-arachidonic acid were analyzed by RP-HPLC (Ultrasphere ODS column, 4.6 ϫ 250 mm, 5 particle size, Alltech, Deerfield, IL) in the solvent system (flow 2 ml/min, column temperature 40 C) methanol/water/acetic acid (80/20/0.1) with flowthrough UV monitoring (203 nm). The arachidonic acid peak (retention time 20 min) was extracted by adding chloroform (2 ml) and 2% acetic acid in water (2 ml), vortex-mixing, and centrifugation (900 ϫ g, 5 min). The chloroform phase was removed and concentrated to dryness and arachidonate and [ 2 H 8 ]-arachidonate converted to pentafluorobenzyl ester (PFBE) derivatives with pentafluorobenzyl bromide and tetramethylammonium hydroxide (33) .
Gas chromatographic/mass spectrometric quantitation of arachidonic acid
Heptane solutions of arachidonate-PFBE were introduced into a Hewlett-Packard 5890 gas chromatograph (GC) via a Grob-type injector (temperature 225 C) in splitless mode and analyzed on an DB-1 capillary column (15 m length, cross-linked methylsilicone, i.d. 0.20 mm, film thickness 0.33 micron, J&W Scientific, Rancho Cordoba, CA) interfaced with a Hewlett-Packard 5988B mass spectrometer. Helium was carrier gas (total flow 10 ml/min, head pressure 4 lb/in 2 ). Injector and interface temperatures were 225 C. At 0.5 min after injection, GC oven temperature was increased from 180 -220 C over 1 min (arachidonate-PFBE retention time 10 min). The mass spectrometer was operated in methane (source pressure 1.5 torr, source temperature 120 C) negative ion chemical ionization mode with a Hewlett-Packard RTE-A data system. Selected monitoring of carboxylate anions from PFBE derivatives of arachidonate (m/z 303) and [ 2 H 8 ]-arachidonate (m/z 311) was performed to quantitate arachidonate by reference to a standard curve (8, 33) .
Isolation of ␤-cells and measurement of cytosolic [Ca 2ϩ ]
Single cell suspensions prepared from islets with dispase (25, 34) were analyzed by fluorescence-activated cell sorting (FACS) on a FACS-Vantage instrument (25, 35) to yield a population of predominantly (Ͼ90%) ␤-cells, as verified by immunocytochemical staining for insulin (36) . Beta cell cytosolic [Ca 2ϩ ] was measured as described (10, 25, 37) after attaching cells (10 5 /ml) to 25 mm diameter Cell-Tak-coated glass coverslips and incubation (37 C, overnight, under 5% CO 2 in air) in cCMRL medium, which was then replaced with 6 mm glucose in KRB medium. Beta cells were incubated (30 min, room temperature, in the dark) with Fura-2 AM (10 m) (10, 25) and rinsed twice with 6 mm glucose in KRB medium. In some cases, ␤-cells were then incubated (15 min, room temperature) with BAPTA-AM (100 m) in 6 mm glucose in KRB medium and rinsed as above. Coverslips with attached ␤-cells were placed in the incubation chamber of a PTI DeltaScan instrument with a Nikon microscope and FURA lens attachment. The chamber contained either 6 mm glucose in KRB medium or buffer (25 mm HEPES, pH 7.4, 115 mm NaCl, 24 mm NaHCO 3 , 5 mm KCl, 1 mm MgCl 2 , 6 mm glucose) with 1 mm EGTA and no added Ca 2ϩ . Dual wavelength excitation (340 and 380 nm) was performed, and the ratio of emission (505 nm) intensities at these wavelengths was monitored as an index of cytosolic [Ca 2ϩ ] until a stable baseline was achieved. Changes in this ratio were then monitored after adding 4-bromo-A23187 (10, 25) .
Preparation of an islet complementary DNA (cDNA) library and isolation of cDNA encoding islet iPLA 2
A cDNA library was constructed from rat islet poly(A)-RNA with a ZAP Express cDNA Gigapack Gold Cloning Kit (Stratagene), and a full-length cDNA encoding rat islet iPLA 2 was isolated from the library in pBK-CMV plasmid and sequenced (38) .
Expression of islet iPLA 2 in Sf9 cells
Spodoptera frugiperda (Sf9) insect cells were used as expression host because they express relatively large amounts of recombinant protein encoded by a cDNA insert when infected with baculovirus vectors (39) . Sf9 cells also perform eukaryotic posttranslational modifications and are used to generate appropriately posttranslationally modified, catalytically active Group IV PLA 2 (cPLA 2 ) from mammalian cPLA 2 cDNA in a baculovirus vector (40) . The islet iPLA 2 cDNA insert was released from pBK-CMV plasmid by digestion with endonucleases EcoRI and XhoI and subcloned into EcoRI and XhoI sites of pBAC-1 baculovirus transfer plasmid (Novagen). Sf9 cells were cotransfected with this transfer plasmid and linearized baculovirus DNA (BacVector-2000, Novagen) to construct a recombinant baculovirus with iPLA 2 cDNA insert. ReadyPlaque Sf9 cells (3 ϫ 10 6 ) in Sf-900II SFM medium were placed in 60-mm tissue culture dishes as a monolayer and incubated (room temperature, 2 h). Recombinant transfer plasmid and linearized BACVector-2000 DNA were incubated (room temperature, 15 min) with Eufectin Transfer Reagent, and Sf-900 II SFM medium was added to this mixture, which was then placed on the Sf9 cell monolayer. After incubation (room temperature, 1 h), agarose/Sf-900II SFM mixture (6 ml) was added to plates containing Sf9 cells. After agarose solidification, Sf-900II SFM medium (3 ml) was placed atop the agarose, and plates were incubated (28 C, 72 h). Plaques were purified by iterations of this process with serial dilutions of recombinant virus. After determination of titer, recombinant baculovirus was used to infect (multiplicity of infection 1.0) Sf9 cells grown in suspensions in 80-ml spinner flasks in Grace's medium (41) . At 48 h after infection, Sf9 cells were collected by centrifugation (500 ϫ g, 10 min), washed with and resuspended in buffer (250 mm sucrose, 25 mm imidazole, pH 8.0), and disrupted by sonication (10 one sec bursts, Vibra Cell sonicator). Cytosol was prepared by sequential centrifugations (10,000 ϫ g for 10 min and 100,000 ϫ g for 60 min) and the second supernatant used for PLA 2 activity assays and chromatographic analyses.
Phospholipase A 2 activity assays
Sf9 cell cytosolic protein was determined by Bio-Rad assay and PLA 2 activity measured in aliquots of cytosol (ϳ20 g protein) added to assay buffer (200 mm Tris-HCl, pH 7.0, total assay volume 200 l) containing either 5 mm EGTA or 10 mm CaCl 2 . Some aliquots of cytosol were pretreated (2 min) with BEL (0.1-10 m) before PLA 2 assay. Reactions were initiated by injecting substrate (l-␣-1-palmitoyl-2-[
14 C]linoleoylphosphatidylcholine, specific activity 50 Ci/mol, final concentration 5 m) in ethanol (5 l). Assay mixtures were incubated (3 min, 37 C, with shaking) and reactions terminated by adding butanol (0.1 ml) and vortexing. After centrifugation (2000 ϫ g, 4 min), products in the butanol layer were analyzed by silica gel G TLC in petroleum ether/ethyl ether/ acetic acid (80/20/1). The TLC plate region containing free linoleate (Rf 0.58) was identified with iodine vapor and scraped into scintillation vials. Released [
14 C]-linoleate was measured by liquid scintillation spectrometry and converted to a PLA 2 specific activity (42) .
Chromatographic analysis of iPLA 2 activity in cytosol from Sf9 cells infected with recombinant baculovirus containing islet iPLA 2 cDNA
Cytosol from infected Sf9 cells was supplemented with 1 mm EGTA and applied to a DEAE-Sephacel column previously equilibrated with buffer A (250 mm sucrose, 25 mm imidazole, pH 8.0, 1 mm EGTA). The column was washed with buffer B (25 mm imidazole, pH 8.0, 1 mm EGTA), and iPLA 2 activity was eluted with a linear NaCl gradient (0 -1 m) in buffer B. Fractions with activity were pooled and applied to an ATP-agarose column previously equilibrated with buffer B. The column was washed with buffer B, 10 mm AMP in buffer B, buffer B, and 1 mm ATP in buffer B. Activity eluted in the ATP solution, and these fractions were pooled, supplemented with 5 mm CaCl 2 , and applied to a 0.5 ml calmodulin-sepharose column, which was washed sequentially with buffer C (25 mm imidazole, pH 8.0) supplemented with CaCl 2 (0.5 mm) and with buffer C containing 4 mm EGTA and no added Ca 2ϩ . The iPLA 2 activity was measured in aliquots of eluant.
Statistical analyses
Student's t test was used for comparisons between only two groups. For experiments involving multiple groups, comparisons were performed by one-way ANOVA with posthoc Newman-Keuls analyses.
The n values specified in the description of data sets refer to measurements performed on separate incubations rather than repeated measurements on different aliquots from the same experiment.
Results
Ionophore A23187 is an important tool for examining effects of Ca 2ϩ release from intracellular compartments (43, 44) . A23187 induces Ca 2ϩ movement down its concentration gradient across cell membranes, and this results in Ca 2ϩ loss from membrane-bound intracellular sequestration sites (43, 44) . A23187 has been reported to have little influence on release of [ 3 H]-arachidonate metabolites from prelabeled islets (30) , and if A23187 does not induce islet phospholipid hydrolysis, loss of Ca 2ϩ from intracellular compartments would be unlikely to contribute to islet phospholipase activation. To more rigorously examine this issue, mass spectrometric methods were employed to determine whether A23187 might induce islet phospholipid hydrolysis.
Islets were incubated without or with A23187 and their phospholipids extracted, mixed with internal standard phospholipids, and analyzed by ESI/MS. Figure 1A Figure 1B illustrates that treating islets with A23187 induced a decline in the abundance of these species relative to the internal standard. Figure 1D illustrates that treating islets with A23187 had little effect on the abundance of these islet GPC species relative to the internal standard.
ESI/tandem MS scanning experiments were performed to identify arachidonate-containing parents in islet phospholipid mixtures. Negative ion analyses were performed to identify parent GPE ions that yield arachidonate anion (m/z 303) as a product upon CAD, an ion observed in the tandem spectra of all arachidonate-containing GPE species (32). Such scans indicated that all three major native GPE species in Fig.  1 , A and B, contain arachidonate (not shown). For species represented by the ions at m/z 722, 750, and 766, the sn-1 substituents are residues of palmitic aldehyde, stearic aldehyde, and stearic acid, respectively (32) . Positive ion analysis were performed to identify parent GPC-Li ϩ ions that yield an ion an m/z 473 as a product upon CAD, which represents the arachidonoyl-glycerophosphoethanol moiety and is common to the tandem spectra of all arachidonate-containing GPC-Li ϩ adducts (31) . Such scans indicated that the parent ions at m/z 788 and 816 in the native islet GPC mixtures in Fig. 1C represent arachidonate-containing species (not shown). The former ion represents (1-palmitoyl, 2-arachidonoyl)-GPC-Li ϩ and the latter (1-stearoyl, 2-arachidonoyl)-GPC-Li ϩ (31, 32). Table 1 summarizes a series of experiments like that in Fig.  1 to examine effects of A23187 on the abundance of major GPE and GPC species in islets. A23187 induced a significant decline in islet arachidonate-containing GPE species but had little effect on the abundance of GPC species. The A23187-induced decline in islet arachidonate-containing GPE species could reflect activation of a phospholipase enzyme that hydrolyzes these molecules. Among the candidate phospholipases are a group IV cytosolic phospholipase A 2 (cPLA 2 ) FIG. 1. Electrospray ionization mass spectrometric analysis of pancreatic islet phospholipids. Isolated islets (300/condition) were incubated in 6 mM glucose KRB medium in the absence (panels A and C) or presence (panels B and D) of ionophore A23187 (10 M). Phospholipids were then extracted, mixed with internal standards, processed, and analyzed by ESI/MS. GPE species were visualized by negative ion analyses (panels A and B), and the ion at m/z 662 represents (15:0/15:0)-GPE internal standard. GPC species were visualized by positive ion analyses (panels C and D), and the ion at m/z 684 represents (14:0/14:0)-GPC internal standard.
(45), a group I secretory PLA 2 (sPLA 2 ) (46), and a group VI cytosolic PLA 2 , (iPLA 2 ), which has recently been cloned from islets (38) . Islet iPLA 2 does not require Ca 2ϩ for catalytic activity and is sensitive to inhibition by a bromoenol lactone (BEL) suicide substrate (38), which is not an effective inhibitor of either cPLA 2 or sPLA 2 (47) (48) (49) (50) (51) (52) . Table 2 illustrates that the A23187-induced decline in arachidonate-containing GPE species was prevented by pre-treating islets with BEL.
If the A23187-induced decline in islet arachidonate-containing GPE species illustrated in Fig. 1 and Tables 1 and 2 reflects hydrolysis of such phospholipids, it might be expected that nonesterified arachidonate would be released from islet phospholipids under these conditions. Isotope dilution gas chromatographic (GC)/MS measurements of nonesterified arachidonate were therefore performed with islet lipid extracts. Such measurements involve monitoring carboxylate anions derived from pentafluorobenzyl ester (PFBE) derivatives of endogenous arachidonate (m/z 303) and [ 2 H 8 ]-arachidonate internal standard (m/z 311) at the appropriate GC retention time (Fig. 2) . Substantial amounts of nonesterified arachidonate were observed in non-BELtreated islets incubated with A23187, and much smaller amounts were observed in islets that had been treated with BEL before incubation with A23187 (Fig. 2) . This is further illustrated in Table 3 . Pretreating islets with BEL reduced both basal arachidonate release (entries 1 vs. 2) and the A23187-induced increment in release (entries 3 vs. 4). Similar effects were not observed with propranolol (Table 3) at a concentration that inhibits islet phosphatidate phosphohydrolase (PAPH) (53, 54) , an enzyme reported to represent an additional target of BEL (52) . Both basal and A23187-induced arachidonate release values were slightly higher in islets treated with propranolol compared with those that were not, but the increments in arachidonate release induced by A23187 were similar in control and propranolol-treated islets, as reflected by comparing the difference between entries 1 and 3 to that between entries 5 and 7 (Table 3) . Islets pretreated with BEL exhibited no increment in arachidonate Islets (300/condition) were incubated with vehicle (control) or with A23187 (10 M) in 6 mM glucose KRB medium. Phospholipids were then extracted, mixed with phospholipid internal standards, processed, and analyzed by negative and positive ion ESI/MS as in Fig. 1 Isolated islets were treated with vehicle only (entries 1 and 2) or 10 M BEL (entries 3 and 4) and then incubated (300/condition) in the absence (entries 1 and 4) or presence (entries 2 and 3) of 10 M A23187 in 6 mM glucose KRB medium. Phospholipids were extracted, mixed with internal standard, and analyzed by negative ion ESI/MS as Fig. 1A . The abundance of ions representing islet arachidonate-containing GPE species (m/z 722, 750, and 766) was divided by the abundance of the ion representing the internal standard (m/z 662) to yield a normalized abundance value. This value was then divided by the normalized abundance of the negative ion at m/z 766 observed in the control condition to yield a normalized relative abundance value, as in Table 1 . The sum of the normalized relative abundances of these ions was computed for each condition. The release when treated with A23187 in the absence or presence of propranolol, as reflected by comparing the difference between entries 2 and 4 and that between entries 6 and 8 (Table 3) .
Because BEL is a poor inhibitor of cPLA 2 and sPLA 2 (47-52), it was considered possible that A23187-induced hydrolysis of arachidonate from islet phospholipids might not be attributable to activation of these Ca 2ϩ -dependent enzymes by A23187-induced rises in cytosolic [Ca 2ϩ ]. To examine this issue, GC/MS measurements of arachidonate release from islets were performed under conditions where effects of A23187 on cytosolic [Ca 2ϩ ] were expected to be blunted or eliminated. As illustrated in Fig. 3 , the A23187-induced increment in arachidonate release from islets incubated in Ca 2ϩ -free, EGTA-containing medium (1.30 Ϯ 0.30 g) was similar to that in Ca 2ϩ -replete medium (1.11 Ϯ 0.14 g), even though A23817 cannot induce Ca 2ϩ influx in the former condition. Effects of loading islets with the intracellular Ca 2ϩ chelator BAPTA, which maintains the cytosolic [Ca 2ϩ ] at a fixed value (44, 55, 56) , were then examined. When islets were loaded with BAPTA and incubated in Ca 2ϩ -free, EGTAcontaining medium, addition of A23187 induced an increment in arachidonate release (1.28 Ϯ 0.21 g) that was similar to that obtained with non-BAPTA-loaded islets in Ca 2ϩ -replete medium (Fig. 3) .
As illustrated in Fig. 4 , BEL prevented arachidonate release induced by treating non-BAPTA-loaded islets or BAPTA-loaded islets with A23187 in Ca 2ϩ -free-EGTA-containing medium. BAPTA-loaded islets incubated in Ca 2ϩ -free medium exhibited increased basal arachidonate release in the absence of A23187 compared with islets that had not been loaded with BAPTA, but the A23187-induced increment in arachidonate release from BAPTA-loaded islets was similar to that from islets that had not been loaded with BAPTA (Fig. 4) . The elevated basal release of arachidonate from BAPTA-loaded cells incubated in Ca 2ϩ -free medium was also prevented by BEL (Fig. 4) .
To determine whether the manipulations in Figs. 3 (57, 58) , and thapsigargin therefore causes Ca 2ϩ loss from such sites. As illustrated in Fig. 6 , thapsigargin induced arachidonate release from islets incubated in Ca 2ϩ -replete medium, and this was prevented by BEL. BAPTA-loaded islets incubated in Ca 2ϩ -free medium again exhibited increased basal arachidonate release compared with non-BAPTA-loaded islets. The thapsigargin-induced increment Beta cells were then placed in fresh buffer (25 mM HEPES, pH 7.4, 115 mM NaCl, 24 mM NaHCO 3 , 5 mM KCl, 1 mM MgCl 2 , 6 mM glucose) that contained either 2.5 mM CaCl 2 (tracing A) or EGTA and no added Ca 2ϩ (tracings B and C). Beta cells were then placed in a microfluorimetry apparatus and the ratio of emission intensity (505 nm) produced by excitation at 340 nm and 380 nm was determined as an index of cytosolic [Ca 2ϩ ]. After a stable baseline was achieved, Ca 2ϩ ionophore was added at the time indicated by the arrow. This experiment is representative of three.
in arachidonate release from BAPTA-loaded islets incubated in Ca 2ϩ -free medium was similar to that with non-BAPTAloaded islets incubated in Ca 2ϩ -replete medium, however, and BEL prevented this response (Fig. 6) .
Hydrolysis of arachidonate from islet phospholipids by a BEL-sensitive mechanism can therefore apparently be triggered by loss of Ca 2ϩ from intracellular sequestration sites even under conditions where no rise in cytosolic [Ca 2ϩ ] occurs. In addition, loading islets with BAPTA and incubating them in Ca 2ϩ -free, EGTA-containing medium induces a fall in cytosolic [Ca 2ϩ ] and an increase in arachidonate release by a BEL-sensitive mechanism, suggesting that a decline in Ca 2ϩ content of islet subcellular compartments, possibly including cytosol, may activate a BEL-sensitive phospholipase that is negatively regulated by Ca 2ϩ . Islet iPLA 2 is BEL-sensitive and does not require Ca 2ϩ for catalytic activity (38) , but it is not known whether the islet enzyme might be negatively modulated by Ca 2ϩ . To explore this possibility, the cDNA encoding islet iPLA 2 was placed in a baculovirus vector (41), and the enzyme was then expressed in Sf9 cells (40) . As illustrated in Fig. 7A , assays conducted in the absence of Ca 2ϩ revealed little PLA 2 activity in the cytosol of native Sf9 cells, but infection of the cells with recombinant baculovirus containing islet iPLA 2 cDNA (pBAC-iPLA 2 ) resulted in expression of such activity. The iPLA 2 activity expressed in infected Sf9 cells was sensitive to inhibition by BEL (Fig. 7B) and was higher when assayed in Ca 2ϩ -free, EGTA-containing buffer than in Ca 2ϩ -supplemented buffer, illustrating the lack of a Ca 2ϩ requirement for catalytic activity (Fig. 7C) .
As illustrated in Fig. 8 , exogenous calmodulin induced a concentration-dependent reduction of iPLA 2 activity in cytosol from Sf9 cells infected with pBAC-iPLA 2 when assays were performed in Ca 2ϩ -supplemented buffer, but calmodulin did not influence iPLA 2 activity when assays were performed in Ca 2ϩ -free, EGTA-containing buffer. This indicates that Ca 2ϩ can partially inhibit iPLA 2 activity by a calmodulin-dependent mechanism. The iPLA 2 enzyme was then partially purified from infected Sf9 cell cytosol by sequential chromatography on DEAE-Sephacel and ATP-agarose. Eluant from the ATP-agarose column which contained iPLA 2 activity was then applied to a calmodulin-sepharose affinity matrix in Ca 2ϩ -containing buffer. The majority (97%) of applied activity adsorbed to the matrix under these conditions and, as illustrated in Fig. 9 , continued elution with Ca 2ϩ -containing buffer failed to remove activity from the column. Upon washing with a Ca 2ϩ -free, EGTA-containing solution, iPLA 2 activity was promptly desorbed (Fig. 9 ). This indicates that recombinant islet iPLA 2 can physically associate with calmodulin in a Ca 2ϩ -dependent manner.
Discussion
Our findings indicate that Ca 2ϩ ionophore A23187 induces a decline in arachidonate-containing-GPE species in pancreatic islets and release of nonesterified arachidonate. The magnitude of A23187-induced arachidonate release is similar in Ca 2ϩ -replete medium; in Ca 2ϩ -free, EGTA-containing medium; or with BAPTA-loaded islets stimulated in Ca 2ϩ -free medium, a condition under which Ca 2ϩ -ionophore induces no rise in ␤-cell cytosolic [Ca 2ϩ ]. That A23187-induced release of arachidonate from islet phospholipids might be triggered by Ca 2ϩ loss from intracellular compartments is suggested by the fact that the SERCA inhibitor thapsigargin also induces arachidonate release of similar magnitude in Ca 2ϩ -replete medium or with BAPTA-loaded cells stimulated in Ca 2ϩ -free medium. Loading islets with BAPTA and incubation in Ca 2ϩ -free medium also induces both a decline in ␤-cell cytosolic [Ca 2ϩ ] and a rise in arachidonate release even in the absence of A23187 or thapsigargin, but both agonists induce an increment in arachidonate release under these conditions that is similar to that with non-BAPTA-loaded islets incubated in Ca 2ϩ -replete medium. Under all conditions, ara- (59) , and a recombinant PLA 2 cloned from CHO cells with a primary structure similar to islet iPLA 2 also interacts with calmodulin affinity matrices (60), suggesting that negative modulation by Ca 2ϩ / calmodulin is not confined to islet iPLA 2 . Such negative modulation might explain how the decline in ␤-cell cytosolic [Ca 2ϩ ] induced by BAPTA activates hydrolysis of arachidonate from islet phospholipids.
It is not clear how the Ca 2ϩ content of intracellular sequestration sites could influence interactions of iPLA 2 and calmodulin, but islets and insulinoma cells also contain substantial amounts of membrane-associated, BEL-sensitive PLA 2 activity that does not require Ca 2ϩ for catalysis (42, 61, 62) but that might be influenced by the Ca 2ϩ content of membrane-bound Ca 2ϩ sequestration sites in some manner. Many aspects of the relationships between the cytosolic and membrane-associated BEL-sensitive PLA 2 activities in islets and the details of their regulation remain to be clarified, but the findings here raise the possibility that such activities could be involved in sensing Ca 2ϩ loss from cytosol and membrane-bound sequestration sites. Regulation of these activities is likely to be complex, and the cytosolic activity may be affected by concentrations of ATP and ADP (62) , by interacting proteins (63) , by posttranslational modifications (60) , and by other factors that remain to be identified.
BEL also inhibits a cytosolic, Mg 2ϩ -dependent isozyme of phosphatidic acid phosphohydrolase (PAPH) (52) . Islets express such PAPH activity (53) , but inhibition of islet cell PAPH activity with propranolol has been reported to stimulate rather than to suppress both arachidonate release from islet cell phospholipids and insulin secretion (54) . Propranolol also does not suppress A23187-induced arachidonate release from islets. These observations do not establish PAPH as an obvious candidate for mediating the Ca 2ϩ -store deple- tion-induced hydrolysis of arachidonate from islet phospholipids that is prevented by BEL.
Regardless of the identity of the BEL-sensitive target(s) that participate in hydrolysis of arachidonate from islet phospholipids, the fact that such hydrolysis can be triggered by Ca 2ϩ loss from intracellular compartments could have implications for islet signaling mechanisms. The earliest change in cytosolic [Ca 2ϩ ] in glucose-stimulated islets is a transient decline to below resting values (11) (12) (13) , and this response is dependent on glucose metabolism, as is hydrolysis of arachidonate from islet phospholipids (64, 65) . It has been proposed that Ca 2ϩ is then released from islet intracellular sequestration sites (14 -16) and that the decline in Ca 2ϩ content of these sites activates an inward cationic current across ␤-cell plasma membranes (17, 18 ) that interacts cooperatively with K ATP channel closure to induce membrane depolarization and opening of voltage-operated Ca 2ϩ channels (19) . This model is similar to the phenomenon of capacitative Ca 2ϩ entry, which involves activation of Ca 2ϩ influx mechanisms in response to Ca 2ϩ loss from intracellular stores (66 -69) . How the filling state of Ca 2ϩ stores is communicated to the plasma membrane is unknown. One possibility is that a diffusible mediator is generated as a consequence of Ca 2ϩ loss from intracellular compartments and traverses cytosol to interact with plasma membrane targets. Observations in differentiated U937 cells, which exhibit capacitative Ca 2ϩ entry, suggest that arachidonic acid might represent one such mediator (43) . Both A23187 and thapsigargin induce Ca 2ϩ loss from U937 cell intracellular sequestration sites and hydrolysis of arachidonate from U937 cell phospholipids (43) . Inhibition of arachidonate release with a nonselective PLA 2 inhibitor prevents capacitative Ca 2ϩ entry in U937 cells, and exogenous arachidonate induces Ca 2ϩ influx (43) . Exogenous arachidonate also induces Ca 2ϩ influx into islet ␤-cells (10, 25) , and BEL attenuates glucose-induced Ca 2ϩ entry into ␤-cells (25) . In various cells, arachidonic acid amplifies Ca 9 . Recombinant islet iPLA 2 activity adsorbs to a calmodulinsepharose matrix and is desorbed by EGTA-containing buffer. Cytosol was prepared from Sf9 cells infected with recombinant baculovirus containing the islet iPLA 2 cDNA insert and analyzed by chromatography on DEAE-Sephacel and then ATP-agarose. Fractions containing Ca 2ϩ -independent PLA 2 activity that eluted from the ATP-agarose column in ATP-containing buffer were pooled, supplemented with 5 mM CaCl 2 , and applied to a calmodulin-sepharose column, which adsorbed 97% of applied activity. The column was then washed sequentially with 25 ml of buffer containing 0.5 mM CaCl 2 and then with 12 ml of buffer containing 4 mM EGTA and no added Ca 2ϩ . The iPLA 2 activity was measured in aliquots of column eluant.
metabolites (26) . These observations imply that depletion of ␤-cell Ca 2ϩ stores induces hydrolysis of arachidonate from ␤-cell phospholipids by a mechanism that does not require a rise in cytosolic [Ca 2ϩ ]. The findings reported here provide a direct demonstration that this occurs, but additional study is required to establish the full functional consequences of Ca 2ϩ -store depletion-induced hydrolysis of arachidonate from islet membrane phospholipids and details of the mechanism by which it occurs.
Under the conditions of the studies performed here, treatment of islets incubated in Ca 2ϩ -replete medium with Ca 2ϩ ionophore A23187 or thapsigargin induced an increment in insulin secretion. The ratio to control values was 2.42 Ϯ 0.03 for A23187-treated islets and 3.92 Ϯ 0.21 for thapsigargintreated islets, and the increment in secretion in induced by these agents was not prevented by pretreating the islets with BEL. In Ca 2ϩ -free, EGTA-containing medium, the corresponding ratios to control insulin secretion values were 0.79 Ϯ 0.17 for A23187-treated islets and 1.36 Ϯ 0.08 for thapsigargin-treated islets, suggesting that insulin secretion in response to these agents is largely dependent on Ca 2ϩ influx from the extracellular space. In contrast, Ca 2ϩ influx is not required for induction of ␤-cell apoptosis in islets treated with thapsigargin or the Ca 2ϩ ionophore ionomycin, although generation of arachidonate 12-lipoxygenase products appears to participate in induction of apoptosis by these agents even under conditions where Ca 2ϩ influx cannot occur (26) . Studies are in progress to determine whether treating islets with thapsigargin or Ca 2ϩ ionophores augments production of arachidonate 12-lipoxygenase products, an effect observed in other circumstances where arachidonate release from islet phospholipids is enhanced (28) .
